{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02816",
      "entity_text" : "proinsulin",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00843",
      "entity_text" : "haemoglobin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Larsen et al., using anakinra, a recombinant human IL-1Ra, in 70 patients with type 2 diabetes mellitus, observed after 13 weeks an improved beta-cell secretory function (reduced glycated haemoglobin level, enhanced C-peptide secretion, reduced ratio of proinsulin to insulin) and a reduction of IL-6 and C-reactive protein, markers of systemic inflammation [XREF_BIBR].",
  "reading_complete" : "2020-08-03T14:31:58Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T14:25:14Z",
  "trigger" : "reduced",
  "evidence" : [ "haemoglobin level, enhanced C-peptide secretion, reduced ratio of proinsulin" ],
  "pmc_id" : "3317136",
  "score" : 0
}